Francis Farraye

Professor of Medicine

Mayo Clinic

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Francis Farraye is a Professor of Medicine at the Mayo Clinic in the United States. His research focuses on inflammatory bowel disease (IBD), with recent articles addressing topics such as the epidemiology of pediatric-onset IBD, clinical guidelines for preventive care in IBD, and the relationship between diabetes and IBD outcomes. Dr. Farraye's work also explores the effectiveness of various treatments for IBD, contributing significantly to the understanding of the condition's management.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Freddy Caldera

University of Wisconsin School of Medicine and Public Health

UNITED STATES

View details

Mary S. Hayney

University of Wisconsin-Madison

UNITED STATES

View details

Manuel B Braga Neto

Assistant Professor

Cleveland Clinic

UNITED STATES

View details

Edward L. Barnes

University of North Carolina

UNITED STATES

View details

Michael D. Kappelman

University of North Carolina at Chapel Hill

UNITED STATES

View details

David Schwartz

Professor of Medicine

Vanderbilt University Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Francis Farraye

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Low Incidence of Varicella in Pediatric Patients With Inflammatory Bowel Disease

ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease

Author's reply: “Insights on regional and demographic patterns of IBD among young women: A comment”

Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study

Oral Extraintestinal Manifestations of Inflammatory Bowel Disease: The Temporal Relationship Between Oral and Intestinal Symptoms

Effectiveness and Safety of Semaglutide for Weight Loss in Patients With Inflammatory Bowel Disease and Obesity

Global Epidemiology and Geographic Variations of Pediatric-Onset Inflammatory Bowel Disease: A Comprehensive Analysis of the Global Burden of Disease Study 1990 to 2019

The Natural History After Ileal Pouch-Anal Anastomosis for Ulcerative Colitis: A Population-Based Cohort Study From the United States

Comparative Effectiveness of Upadacitinib and Tofacitinib in Ulcerative Colitis: A US Propensity-Matched Cohort Study

Risk of Small Intestine Cancer in Inflammatory Bowel Disease: A Propensity-Matched Study From a Large Multicenter Database in the United States

Baseline Clinical Factors are Associated with Risk of Complications in Crohn’s Disease: Appraisal of the AGA Clinical Care Pathway

New Pneumococcal Vaccines for Prevention of Invasive Pneumococcal Disease in Adult Patients With Inflammatory Bowel Disease

A Cohort Study of the Age at Menopause in Female Patients With and Without Inflammatory Bowel Disease

Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic Colitis

Oral Contraceptive Pills Are an Effective Method of Preventing Pregnancy in Women With Crohn’s Disease

Incidence, outcomes, and impact of COVID‐19 on inflammatory bowel disease: propensity matched research network analysis

On-site Availability Improves Vaccination Rates in Patients With Inflammatory Bowel Disease

The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programme

Patterns of endoscopy during COVID-19 pandemic: a global survey of interventional inflammatory bowel disease practice

Effectiveness of recombinant zoster vaccine (RZV) in patients with inflammatory bowel disease

Collaborators (6)

Freddy Caldera

Mary S. Hayney

Manuel B Braga Neto

Edward L. Barnes

Michael D. Kappelman

David Schwartz

Make your next move.